Golden has been acquired by ComplyAdvantage.Read about it here ⟶

Halo-Bio RNAi Therapeutics

Halo-Bio was formed in 2008 to develop and patent a novel RNAi technologies for human therapeutics.

Overview Structured Data Issues Contributors Activity

halo-bio.com

Is a

Organization

Company

Company attributes

Industry

RNA

Therapeutics

Technology

RNA-based and RNA-targeted therapeutics

Biology

...

Location

‌

Seattle, Washington, United States

B2X

CEO

Founder

Number of Employees (Ranges)

1 – 10

Full Address

4111 E. Madison St., 140 Seattle, WA 98112

Patents Assigned (Count)

Other attributes

Company Operating Status

Active

Halo-bio RNAi Therapuetics biopharmaceutical development efforts have utilized synthetic polyplexes, lipid nanoparticles, ligand-directed attachments or modified chemistries in an effort to deliver RNA to diseased organs.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more companies like Halo-Bio RNAi Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.

Open Query Tool

Access by API